Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).

ABSTRACT:

SUBMITTER: Flaxman A 

PROVIDER: S-EPMC8409975 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature